Nanostructures for Drug Delivery extensively covers the various nanostructured products that have been tested as carriers in target drug delivery systems. In addition, the book analyses the advantages of, and issues related to, using nanostructured materials in drug delivery systems, also detailing various nanocarrier preparation techniques.
As delivering the drug to the target site is a major problem in providing effective treatment for many diseases, this book covers the latest advancements in numerous nanotechnological products that are being used in disease detection, controlled drug delivery, as biosensors, and in tissue engineering that have been developed for more efficient patient healthcare. Due to the versatility of nanostructured materials, it is now possible to deliver a drug at its target site in a more accurate and efficient way.
This volume is an up-to-date, state-of-the-art work that highlights the principal mechanistic aspects related to the delivery of active nanoscale therapeutic agents (natural or synthetic) and their release profile in different environmental media. It highlights nanoscale encapsulation strategies and discusses both organic and inorganic nanomaterials as carriers and delivery platforms.
1. Cover - p. i 2. Title page - p. iii 3. Table of Contents - p. iii 4. Copyright - p. ii 5. List of Contributors - p. iv 6. Foreword of the Series - p. xxix 7. Preface - p. xxxii 8. Chapter 1: Therapeutic nanomaterials: from a drug delivery perspective - p. xxxvii 9. Chapter 2: Core–shell drug carriers: liposomes, polymersomes, and niosomes - p. 61 10. Chapter 3: The new nanocarriers based on graphene and graphene oxide for drug delivery applications - p. 105 11. Chapter 4: Nanostructured nanoparticles for improved drug delivery - p. 147 12. Chapter 5: Design of functionalized materials for use in micronanoscale drug delivery devices and smart patches - p. 182 13. Chapter 6: Niosomes: a novel approach in modern drug delivery systems - p. 206 14. Chapter 7: Nanofibrous and nanoparticle materials as drug-delivery systems - p. 237 15. Chapter 8: Brush polymer-based nanostructures for drug delivery - p. 270 16. Chapter 9: Drug delivery systems based on titania nanostructures - p. 298 17. Chapter 10: Redox activated polymeric nanoparticles in tumor therapy - p. 326 18. Chapter 11: Polymeric micro- and nanoparticles for controlled and targeted drug delivery - p. 354 19. Chapter 12: Novel gels: implications for drug delivery - p. 378 20. Chapter 13: Nanosuspension drug delivery system: preparation, characterization, postproduction processing, dosage form, and application - p. 412 21. Chapter 14: Polymer-based nanocarriers for therapeutic nucleic acids delivery - p. 443 22. Chapter 15: Multifunctional therapeutic hybrid nanocarriers for targeted and triggered drug delivery: recent trends and future prospects - p. 460 23. Chapter 16: Lipid-based nanocarriers for ocular drug delivery - p. 493 24. Chapter 17: Nanoparticulate carrier(s): an emerging paradigm in new generation vaccine development - p. 522 25. Chapter 18: Pathogen-specific nucleic acid aptamers as targeting components of antibiotic and gene delivery systems - p. 550 26. Chapter 19: Multifunctional nanosized emulsions for theragnosis of life threatening diseases - p. 577 27. Chapter 20: Therapeutic nanostructures for pulmonary drug delivery - p. 617 28. Chapter 21: Nanostructures in transdermal drug delivery systems - p. 638 29. Chapter 22: Advancement in pulmonary drug delivery systems for treatment of tuberculosis - p. 668 30. Chapter 23: Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook - p. 695 31. Chapter 24: Drug delivery mediated by confined nanosystems: structure-activity relations and factors responsible for the efficacy of formulations - p. 748 32. Chapter 25: Therapeutic use of monoclonal antibodies: general aspects and challenges for drug delivery - p. 806 33. Chapter 26: Targeted drug delivery via chitosan-coated magnetic nanoparticles - p. 833 34. Chapter 27: Drug delivery: advancements and challenges - p. 864 35. Chapter 28: Stimuli-responsive liposome and control release drug - p. 886 36. Chapter 29: Nanotechnology to enhance transdermal delivery of hydrophilic humectants for improved skin care: a model for therapeutic applications - p. 917 37. Chapter 30: Nanostructures for drug delivery: pharmacokinetic and toxicological aspects - p. 939 38. Index - p. 957
Nanostructures for Drug Delivery extensively covers the various nanostructured products that have been tested as carriers in target drug delivery systems. In addition, the book analyses the advantages of, and issues related to, using nanostructured materials in drug delivery systems, also detailing various nanocarrier preparation techniques.
As delivering the drug to the target site is a major problem in providing effective treatment for many diseases, this book covers the latest advancements in numerous nanotechnological products that are being used in disease detection, controlled drug delivery, as biosensors, and in tissue engineering that have been developed for more efficient patient healthcare. Due to the versatility of nanostructured materials, it is now possible to deliver a drug at its target site in a more accurate and efficient way.
This volume is an up-to-date, state-of-the-art work that highlights the principal mechanistic aspects related to the delivery of active nanoscale therapeutic agents (natural or synthetic) and their release profile in different environmental media. It highlights nanoscale encapsulation strategies and discusses both organic and inorganic nanomaterials as carriers and delivery platforms.
1. Cover - p. i 2. Title page - p. iii 3. Table of Contents - p. iii 4. Copyright - p. ii 5. List of Contributors - p. iv 6. Foreword of the Series - p. xxix 7. Preface - p. xxxii 8. Chapter 1: Therapeutic nanomaterials: from a drug delivery perspective - p. xxxvii 9. Chapter 2: Core–shell drug carriers: liposomes, polymersomes, and niosomes - p. 61 10. Chapter 3: The new nanocarriers based on graphene and graphene oxide for drug delivery applications - p. 105 11. Chapter 4: Nanostructured nanoparticles for improved drug delivery - p. 147 12. Chapter 5: Design of functionalized materials for use in micronanoscale drug delivery devices and smart patches - p. 182 13. Chapter 6: Niosomes: a novel approach in modern drug delivery systems - p. 206 14. Chapter 7: Nanofibrous and nanoparticle materials as drug-delivery systems - p. 237 15. Chapter 8: Brush polymer-based nanostructures for drug delivery - p. 270 16. Chapter 9: Drug delivery systems based on titania nanostructures - p. 298 17. Chapter 10: Redox activated polymeric nanoparticles in tumor therapy - p. 326 18. Chapter 11: Polymeric micro- and nanoparticles for controlled and targeted drug delivery - p. 354 19. Chapter 12: Novel gels: implications for drug delivery - p. 378 20. Chapter 13: Nanosuspension drug delivery system: preparation, characterization, postproduction processing, dosage form, and application - p. 412 21. Chapter 14: Polymer-based nanocarriers for therapeutic nucleic acids delivery - p. 443 22. Chapter 15: Multifunctional therapeutic hybrid nanocarriers for targeted and triggered drug delivery: recent trends and future prospects - p. 460 23. Chapter 16: Lipid-based nanocarriers for ocular drug delivery - p. 493 24. Chapter 17: Nanoparticulate carrier(s): an emerging paradigm in new generation vaccine development - p. 522 25. Chapter 18: Pathogen-specific nucleic acid aptamers as targeting components of antibiotic and gene delivery systems - p. 550 26. Chapter 19: Multifunctional nanosized emulsions for theragnosis of life threatening diseases - p. 577 27. Chapter 20: Therapeutic nanostructures for pulmonary drug delivery - p. 617 28. Chapter 21: Nanostructures in transdermal drug delivery systems - p. 638 29. Chapter 22: Advancement in pulmonary drug delivery systems for treatment of tuberculosis - p. 668 30. Chapter 23: Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook - p. 695 31. Chapter 24: Drug delivery mediated by confined nanosystems: structure-activity relations and factors responsible for the efficacy of formulations - p. 748 32. Chapter 25: Therapeutic use of monoclonal antibodies: general aspects and challenges for drug delivery - p. 806 33. Chapter 26: Targeted drug delivery via chitosan-coated magnetic nanoparticles - p. 833 34. Chapter 27: Drug delivery: advancements and challenges - p. 864 35. Chapter 28: Stimuli-responsive liposome and control release drug - p. 886 36. Chapter 29: Nanotechnology to enhance transdermal delivery of hydrophilic humectants for improved skin care: a model for therapeutic applications - p. 917 37. Chapter 30: Nanostructures for drug delivery: pharmacokinetic and toxicological aspects - p. 939 38. Index - p. 957
